In a shocking turn of events, the World Trade Center Health Program (WTCHP), a beacon of hope for 9/11 responders and survivors, faces devastating cuts. Under the Trump administration, the program has experienced a 20% reduction in staff, resulting from layoffs and buyouts, which will impact services to 137,000 individuals. These cuts threaten to delay treatment and limit the program’s ability to provide necessary medical support.
With over 80 diseases, including 60+ cancers, linked to the toxic exposure from the World Trade Center collapse, the WTCHP provides no-cost medical monitoring and treatment to those affected. Now, the future of this crucial care is uncertain.
This blog will delve into the repercussions of these cuts, exploring how they affect access to timely care, research into emerging health needs, and the overall well-being of the heroes and survivors who depend on this program.
Listen to the Deep Dive Below
Producer
